je.st
news
X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG
2014-12-29 01:28:39| drugdiscoveryonline Home Page
X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, recently announced it has licensed a second drug discovery program to Bayer Pharma AG pursuant to the multi-target collaboration the companies established in July 2012
Tags: program
drug
discovery
licenses
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||